tailieuchung - Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Đang chuẩn bị liên kết để tải về tài liệu:
Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Công Vinh 42 12 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Molecular targeted therapy for non-small cell lung carcinoma (NSCLC) is restricted due to resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study evaluated the efects of dual targeting of MEK and PI3K in human EGFR-TKI resistant NSCLC cell lines. |

Đang chuẩn bị liên kết để tải về tài liệu:
Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Molecular targeted therapy for non-small cell lung carcinoma (NSCLC) is restricted due to resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study evaluated the efects of dual targeting of MEK and PI3K in human EGFR-TKI resistant NSCLC cell lines. |

Báo cáo khoa hoc : Fumarase: a paradigm of dual targeting and dual localized functions

Báo cáo khoa học: Protein transport in organelles: Dual targeting of proteins to mitochondria and chloroplasts

báo cáo khoa học: "Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways"

Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

MicroRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer

In vivo dual targeting of the oncogenic Ether-àgo-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors

MiR93-5p inhibits chondrocyte apoptosis in osteoarthritis by targeting lncRNA CASC2

Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

Đang chuẩn bị liên kết để tải về tài liệu: Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Molecular targeted therapy for non-small cell lung carcinoma (NSCLC) is restricted due to resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study evaluated the efects of dual targeting of MEK and PI3K in human EGFR-TKI resistant NSCLC cell lines. |

Báo cáo khoa hoc : Fumarase: a paradigm of dual targeting and dual localized functions

Báo cáo khoa học: Protein transport in organelles: Dual targeting of proteins to mitochondria and chloroplasts

báo cáo khoa học: "Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways"

Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

MicroRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer

In vivo dual targeting of the oncogenic Ether-àgo-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors

MiR93-5p inhibits chondrocyte apoptosis in osteoarthritis by targeting lncRNA CASC2

Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

Đang chuẩn bị liên kết để tải về tài liệu:
Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds